| 22nd Dec 2021 11:05 am |
EQS |
Arix Bioscience PLC: Arix Bioscience co-leads $31 million Series A financing for new portfolio company Sorriso Pharmaceuticals |
| 17th Dec 2021 11:13 am |
EQS |
Arix Bioscience PLC: Director/PDMR Shareholdings |
| 17th Dec 2021 7:00 am |
RNS |
Director/PDMR Shareholding |
| 15th Dec 2021 8:14 am |
EQS |
Arix Bioscience PLC: Depixus raises €30.6M (£26.1 million) in Series A Financing |
| 13th Dec 2021 3:54 pm |
EQS |
Arix Bioscience PLC: Imara Presents Clinical and Preclinical Tovinontrine (IMR-687) Data at the American Society of Hematology (ASH) Annual Meeting 2021 |
| 13th Dec 2021 3:51 pm |
EQS |
Arix Bioscience PLC: Autolus Therapeutics presents positive obe-cel data at the American Society of Hematology (ASH) Annual Meeting 2021 |
| 17th Nov 2021 5:04 pm |
EQS |
Imara Announces Interim Analysis Data From Forte Phase 2b Clinical Trial Of Tovinontrine (Imr-687) In Transfusion-Dependent Subjects With Beta-Thalassemia |
| 8th Nov 2021 5:34 pm |
EQS |
Transaction in own shares |
| 8th Nov 2021 1:00 pm |
EQS |
Arix Bioscience PLC: Blackstone Life Sciences to invest up to $250 million in Autolus Therapeutics to develop obe-cel in adult Acute Lymphoblastic Leukemia (ALL) and advance broader platform |
| 8th Nov 2021 7:01 am |
EQS |
Arix Managing Director to Participate in Fireside Chat at the Jefferies Healthcare Conference |
| 1st Nov 2021 7:01 am |
EQS |
Total Voting Rights |
| 29th Oct 2021 7:00 am |
EQS |
Aura Biosciences prices Nasdaq IPO |
| 18th Oct 2021 4:48 pm |
EQS |
LogicBio Therapeutics Announces Early Clinical Trial Results Demonstrating First-Ever In Vivo Genome Editing in Children |
| 18th Oct 2021 7:00 am |
EQS |
Business Update and Cancellation of Share Buyback |
| 15th Oct 2021 5:30 pm |
EQS |
Transaction in own shares |
| 14th Oct 2021 5:30 pm |
EQS |
Transaction in own shares |
| 13th Oct 2021 5:30 pm |
EQS |
Transaction in own shares |
| 13th Oct 2021 5:28 pm |
EQS |
TR1: Notification of Major Shareholding |
| 12th Oct 2021 5:30 pm |
EQS |
Transaction in own shares |
| 12th Oct 2021 1:02 pm |
EQS |
Aura Biosciences Presents Interim Phase 2 Safety Data Evaluating Suprachoroidal Administration of AU-011 in Patients with Choroidal Melanoma at the ASRS 2021 Annual Meeting |
| 11th Oct 2021 5:30 pm |
EQS |
Transaction in own shares |
| 8th Oct 2021 5:30 pm |
EQS |
Transaction in own shares |
| 8th Oct 2021 10:11 am |
EQS |
Pyxis Oncology prices Nasdaq IPO - Update |
| 8th Oct 2021 7:00 am |
EQS |
Pyxis Oncology prices Nasdaq IPO |
| 7th Oct 2021 5:30 pm |
EQS |
Transaction in own shares |
| 6th Oct 2021 5:30 pm |
EQS |
Transaction in own shares |
| 6th Oct 2021 7:00 am |
EQS |
Board Changes |
| 5th Oct 2021 5:30 pm |
EQS |
Transaction in own shares |
| 4th Oct 2021 5:30 pm |
EQS |
Transaction in own shares |
| 1st Oct 2021 5:30 pm |
EQS |
Transaction in own shares |
| 1st Oct 2021 7:00 am |
EQS |
Total Voting Rights |
| 30th Sep 2021 5:30 pm |
EQS |
Transaction in own shares |
| 29th Sep 2021 5:30 pm |
EQS |
Transaction in own shares |
| 28th Sep 2021 5:30 pm |
EQS |
Transaction in own shares |
| 28th Sep 2021 8:16 am |
EQS |
Artios Doses First Patient in Phase 1/2a Study of Polθ Inhibitor ART4215 |
| 27th Sep 2021 5:30 pm |
EQS |
Transaction in own shares |
| 24th Sep 2021 5:30 pm |
EQS |
Transaction in own shares |
| 23rd Sep 2021 5:30 pm |
EQS |
Transaction in own shares |
| 22nd Sep 2021 5:30 pm |
EQS |
Transaction in own shares |
| 21st Sep 2021 6:00 pm |
EQS |
Transaction in own shares |
